SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-004394
Filing Date
2018-03-05
Accepted
2018-03-05 17:03:29
Documents
71
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fate-10k_20171231.htm 10-K 3234924
2 EX-10.5 fate-ex105_89.htm EX-10.5 96548
3 EX-10.8 fate-ex108_147.htm EX-10.8 63448
4 EX-10.32 fate-ex1032_90.htm EX-10.32 38134
5 EX-23.1 fate-ex231_6.htm EX-23.1 4747
6 EX-31.1 fate-ex311_8.htm EX-31.1 9804
7 EX-32.1 fate-ex321_9.htm EX-32.1 6936
8 GRAPHIC g2018030521411469735210.jpg GRAPHIC 31916
  Complete submission text file 0001564590-18-004394.txt   11213597

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT fate-20171231.xml EX-101.INS 2492563
10 XBRL TAXONOMY EXTENSION SCHEMA fate-20171231.xsd EX-101.SCH 65638
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fate-20171231_cal.xml EX-101.CAL 65421
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fate-20171231_def.xml EX-101.DEF 284560
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20171231_lab.xml EX-101.LAB 558403
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20171231_pre.xml EX-101.PRE 437845
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36076 | Film No.: 18667079
SIC: 2836 Biological Products, (No Diagnostic Substances)